Patent

July 18, 2025
Blog
No Comments

Delhi High Court Reiterates Limits on Patentability of Software-Based Inventions

On July 1, 2025, in Kroll Information Assurance, LLC v. The Controller General of Patents, Designs and Trademarks & Ors.1, the Delhi High Court upheld the refusal of a patent application under Section 3(k) of the Indian Patents Act, 1970, reaffirming that a mere sequence of instructions or abstract profiling logic is insufficient for patent […]

June 20, 2025
Blog
No Comments

No Patent For Intermediates without Efficacy

Introduction On May 27, 2025, in Zeria Pharmaceutical Co. Ltd. v. Deputy Controller of Patents and Designs1, the Delhi High Court upheld the refusal of divisional patent, affirming that minor structural modifications of known pharmaceutical compounds—especially intermediates—must still demonstrate enhanced therapeutic efficacy to be patentable under Section 3(d) of the Indian Patents Act, 1970. The […]

June 9, 2025
Blog
No Comments

When Coverage Isn’t Disclosure: DelhiHC’s Denies Interim Injunction forRisdiplam

Introduction On March 25, 2025, the Delhi High Court denied the request of F. Hoffmann-La Roche AG for an interim injunction against Natco Pharma in a high-stakes pharmaceutical patent dispute in F. Hoffmann-La Roche Ag & Anr. vs Natco Pharma Limited [1]1. At issue was Roche’s species patent on “Risdiplam,” a life-saving drug for Spinal […]

May 28, 2025
Blog
No Comments

India’s Biosimilar Pathway Gets an Update in the Draft 2025 Guidelines

Introduction India’s regulatory landscape for biologic and biosimilar medicines continues to evolve. In response to scientific advances and accumulated regulatory experience, the Central Drugs Standard Control Organization (CDSCO) and the Department of Biotechnology (DBT) have jointly released the Draft Guidelines on Similar Biologics – Regulatory Requirements for Marketing Authorization in India, 2025. These proposed guidelines […]

May 23, 2025
Blog
No Comments

A Power of Attorney Dispute that Went Too Far

In a significant judgment dated April 22, 2025, the Calcutta High Court (Original Side, Intellectual Property Rights Division) allowed Huawei Technologies Co. Ltd. v. Controller General of Patents, Designs, and Trademarks [1]1, emphatically setting aside a 40-page rejection order passed by the Controller of Patents. The Court held that the application had been rejected not […]

May 12, 2025
Blog
No Comments

Trade Secret Protection in India: A Comprehensive Overview

Introduction Trade secrets are crucial to modern business strategy, particularly in sectors driven by innovation, technology, or unique practices. Unlike patents, which require formal registration and public disclosure, trade secrets are protected through confidentiality and non-disclosure agreements (NDAs). In India, the growing importance of trade secret protection is driven by intensifying local and global competition. […]

May 8, 2025
Blog
No Comments

Delhi High Court Reins in Patent Claim Amendments: AbbVie’s Attempt to Convert Method Claims Rejected

Delhi High Court Reins in Patent Claim Amendments: AbbVie’s Attempt to Convert Method Claims Rejected Introduction In a recent judgment in Abbvie Biotherapeutics INC & ANR. v. Assistant Controller of Patents and Designs [1]1, the Delhi High Court upheld the patent refusal order issued by the Controller of Patents for Indian patent application No. 201817047767, […]

May 1, 2025
Blog
No Comments

Patent Lanscape 2023-24: Progress, Challenges and the Road Ahead

The Indian Patent Office (IPO) published its Annual Report on March 31, 2025 spanning activities from April 2023 to March 2024. The report showcases significant growth in filing of applications, expedited examinations and active international collaboration. This article summarizes the main insights from the year’s patent activity. Rising Patent Filings In 2023–24, 92,168 patent applications […]

April 30, 2025
Blog
No Comments

Analyzing the Draft Computer-Related Inventions (CRI) Guidelines 2025 – Part 5: Determination of Excluded Subject Matter

Introduction This article is the final part of our multi-blog series on analyzing the Draft Computer-Related Inventions (CRI) Guidelines, 2025. Part 1 discusses the new definitions and terms introduced in the Guidelines, Part 2 discusses the judgments referred to in the Guidelines, Part 3 discusses the novelty and inventive step sections and Part 4 discusses […]

April 21, 2025
Blog
No Comments

Analyzing the Draft Computer-related Inventions (CRI) Guidelines 2025 – Part 4: Sufficiency of Disclosure

Introduction This article is part 4 of our multi-blog series on analyzing the Draft Computer-Related Inventions (CRI) Guidelines, 2025. Part 1 discusses the new definitions and terms introduced in the Guidelines, Part 2 discusses the judgments referred to in the Guidelines, and Part 3 discusses the novelty and inventive step sections. On March 25, 2025, […]